tradingkey.logo

MiMedx Group Inc

MDXG

7.150USD

+0.210+3.03%
終値 09/18, 16:00ET15分遅れの株価
1.06B時価総額
32.87直近12ヶ月PER

MiMedx Group Inc

7.150

+0.210+3.03%
詳細情報 MiMedx Group Inc 企業名
MiMedx Group, Inc. is a placental biologics company. The Company is engaged in developing and distributing placental tissue allografts with patent-protected, processes for multiple sectors of healthcare. Its product portfolio categories include Wound Care Products, and Surgical and Other Products. Its Wound Care Products include EPIFIX, EPICORD and EPIEFFECT, which are all marketed for external use, such as in advanced wound care applications. Its Surgical and Other product offering includes AMNIOFIX, AMNIOCORD and AMNIOEFFECT, which are positioned for use in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. The Company's platform technologies include tissue allografts derived from the human placental membrane, tissue allografts derived from the human umbilical cord, and a particulate extracellular matrix derived from the human placental disc.
企業情報
企業コードMDXG
会社名MiMedx Group Inc
上場日Aug 20, 2007
最高経営責任者「CEO」Mr. Joseph H. (Joe) Capper
従業員数837
証券種類Ordinary Share
決算期末Aug 20
本社所在地1775 W Oak Commons Court, Ne
都市MARIETTA
証券取引所NASDAQ Capital Market Consolidated
United States of America
郵便番号30062
電話番号17706519100
ウェブサイトhttps://mimedx.com/
企業コードMDXG
上場日Aug 20, 2007
最高経営責任者「CEO」Mr. Joseph H. (Joe) Capper
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
529.53K
+60.69%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
212.77K
+15.53%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
190.25K
-57.15%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
+18.66%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
89.04K
--
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
57.60K
+98.69%
Mr. William A. (Bill) Hawkins, III
Mr. William A. (Bill) Hawkins, III
Independent Director
Independent Director
--
--
Mr. Douglas C. Rice
Mr. Douglas C. Rice
Chief Financial Officer
Chief Financial Officer
--
--
Mr. K. Todd Newton
Mr. K. Todd Newton
Independent Director
Independent Director
--
--
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
529.53K
+60.69%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
212.77K
+15.53%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
190.25K
-57.15%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
+18.66%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
89.04K
--
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
57.60K
+98.69%
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
事業別USD
会社名
収益
比率
Advanced Wound Care
56.07M
63.57%
Surgical
32.13M
36.43%
データなし
事業別
地域別
事業別USD
会社名
収益
比率
Advanced Wound Care
56.07M
63.57%
Surgical
32.13M
36.43%
株主
更新時刻: Fri, Aug 15
更新時刻: Fri, Aug 15
株主統計
種類
株主統計
株主統計
比率
EW Healthcare Partners
19.06%
BlackRock Institutional Trust Company, N.A.
5.95%
Trigran Investments, Inc.
5.67%
The Vanguard Group, Inc.
4.69%
Paradigm Capital Management, Inc.
3.01%
他の
61.63%
株主統計
株主統計
比率
EW Healthcare Partners
19.06%
BlackRock Institutional Trust Company, N.A.
5.95%
Trigran Investments, Inc.
5.67%
The Vanguard Group, Inc.
4.69%
Paradigm Capital Management, Inc.
3.01%
他の
61.63%
種類
株主統計
比率
Venture Capital
19.08%
Investment Advisor
18.90%
Investment Advisor/Hedge Fund
18.84%
Hedge Fund
11.98%
Research Firm
1.89%
Individual Investor
1.83%
Pension Fund
0.49%
Bank and Trust
0.35%
Insurance Company
0.03%
他の
26.60%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
451
106.45M
71.95%
-3.98M
2025Q1
460
106.92M
72.40%
-5.30M
2024Q4
455
107.57M
73.21%
-3.01M
2024Q3
429
103.18M
70.48%
-6.90M
2024Q2
424
100.59M
68.44%
-3.52M
2024Q1
405
106.53M
74.65%
+1.42M
2023Q4
391
100.91M
86.85%
+27.80M
2023Q3
385
72.00M
62.20%
-22.83M
2023Q2
375
65.55M
56.85%
-21.21M
2023Q1
361
82.89M
72.72%
-885.21K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
EW Healthcare Partners
28.20M
19.09%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
8.58M
5.81%
+179.59K
+2.14%
Mar 31, 2025
Trigran Investments, Inc.
7.60M
5.15%
-21.96K
-0.29%
Mar 31, 2025
The Vanguard Group, Inc.
6.69M
4.53%
+5.46K
+0.08%
Mar 31, 2025
Paradigm Capital Management, Inc.
4.68M
3.17%
-2.73K
-0.06%
Mar 31, 2025
State Street Global Advisors (US)
3.46M
2.34%
+189.21K
+5.79%
Mar 31, 2025
Geode Capital Management, L.L.C.
2.91M
1.97%
+133.11K
+4.79%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
2.01M
1.36%
+206.79K
+11.47%
Mar 31, 2025
Renaissance Technologies LLC
1.93M
1.31%
+125.72K
+6.97%
Mar 31, 2025
Cannell Capital, LLC
2.13M
1.44%
-1.51M
-41.39%
Mar 31, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI